Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Cancer Limited Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07559786
What this trial is testing

A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

Who this might be right for
SCLC, Limited Stage
Henan Cancer Hospital 200
Early research (Phase 1)Looking for participantsNCT07391670
What this trial is testing

A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab

Who this might be right for
Solid Tumours
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT01935336
What this trial is testing

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers

Who this might be right for
Adenocarcinoma of the LungExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung Cancer+5 more
University of Colorado, Denver 171
Testing effectiveness (Phase 2)Study completedNCT00191763
What this trial is testing

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-Lung Cancer
Eli Lilly and Company 52
Large-scale testing (Phase 3)Looking for participantsNCT07195695
What this trial is testing

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Who this might be right for
Non-small Cell Lung Cancer
Boehringer Ingelheim 400
Early research (Phase 1)UnknownNCT05942508
What this trial is testing

A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy

Who this might be right for
Limited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy
Jinming Yu 20
Testing effectiveness (Phase 2)Study completedNCT00058006
What this trial is testing

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Northwestern University
Large-scale testing (Phase 3)UnknownNCT04500145
What this trial is testing

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 350
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Testing effectiveness (Phase 2)Looking for participantsNCT05613452
What this trial is testing

Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Proton and Heavy Ion Center 43
Testing effectiveness (Phase 2)Ended earlyNCT01342770
What this trial is testing

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 6
Not applicableLooking for participantsNCT06862869
What this trial is testing

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 800
Testing effectiveness (Phase 2)Looking for participantsNCT06542159
What this trial is testing

Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases

Who this might be right for
Adaptive RadiotherapyStereotactic Body RadiotherapyNon-small Cell Lung Cancer+2 more
Sun Yat-sen University 130
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07167459
What this trial is testing

Personalized SBRT in Early-Stage Peripheral NSCLC

Who this might be right for
Early-stage Peripheral Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 251
Testing effectiveness (Phase 2)Ended earlyNCT03050554
What this trial is testing

SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Andrew Sharabi 2
Not applicableStudy completedNCT02562027
What this trial is testing

SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Washington University School of Medicine 217
Not applicableLooking for participantsNCT05502523
What this trial is testing

The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+1 more
Thomas Jefferson University 100
Not applicableEnded earlyNCT01188486
What this trial is testing

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Who this might be right for
Lung CancerLung Cancer Non-Small Cell Cancer (NSCLC)Lung Cancer Small Cell Lung Cancer (SCLC)+1 more
Stanford University 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06978153
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Tang-Du Hospital 66
Testing effectiveness (Phase 2)Ended earlyNCT04638582
What this trial is testing

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
McGill University Health Centre/Research Institute of the McGill University Health Centre 6
Next Page